#P01

P1: Anatomy of a False Claims Act Case Katherine Lauer, Partner, Latham & Watkins, LLP Colin Huntley, Assistant Director, Commercial Litigation Branch, Fraud Section, Civil Division, U.S. DOJ Madeline Bainer, Senior Counsel, HHS-OIG View Description

• The Investigation Phase: subpoenas/ CIDs, data analysis, witness interviews and more
• The Negotiation Phase: initiation, ADR, scope of release, monetary and other issues
• The Resolution Phase: settlement agreements, individual liability, CIAs/ OIG and relator issues

General Compliance

#P02

P2: Corporate Integrity Agreements: The Role of an Independent Review Organization (IRO) Steven Ortquist, Founder & Principal, Arete Compliance Solutions, LLC Glennon Moyers, Partner, KPMG LLP Amanda Copsey, ACRB Senior Counsel, Office of the Inspector General, US Department of Health and Human Services View Description

• Why do CIAs include an IRO? Frequently utilized review requirements
• How have the roles and obligations of IRO been modified in recent years? What is behind the modifications?
• Working with your IRO: Keys to a Successful IRO engagement

General Compliance

#P03

P3: Navigating Enforcement Action, Investigations, and Settlements Ana-Cristina Navarro, Deputy Chief Compliance Officer, HealthRIGHT360 Anne Daly, Chief Compliance & Integrity Officer, Ann & Robert H. Lurie Children's Hospital of Chicago Christina Villa, Compliance Coordinator, Adventist Health View Description

• This session will provide an overview, through a case study, of how an organization can have an adverse event lead them down the path of government surveys and formal enforcement actions on multiple levels, including a 195 item Systems Improvement Agree
• Illustrate how a compliance team can, and should, assist in facilitating the planning and actions needed to not only overhaul a Health Care Organization’s (HCO) policies and training, but also to support the change in culture needed to sustain
• Provide tools and methods for supporting the organization wide efforts, as well as lessons learned and mechanisms to help prevent your organization from having to navigate the choppy waters of a formal enforcement action

General Compliance

#P04

P4: Litigating a False Claims Act Case Latour Lafferty, Of Counsel, Gunster, Yoakley & Stewart, PA John Boese, Of Counsel, Fried, Frank, Harris, Shriver & Jacobson LLP Robert Vogel, Partner, Vogel, Slade & Goldstein, LLP Patrick Klein, Senior Trial Counsel, Department of Justice View Description

• Common motions in FCA litigation
• Proving/disproving falsity, knowledge and damages after Escobar
• Discovery and trial issues in intervened vs. non-intervened cases
• Escobar-related discovery from the government regarding claims payment

General Compliance

#P05

P5: Anti-Kickback Developments Sally Molloy, Chief, Strategy, Policy and Training Unit, U.S. Department of Justice, Criminal Division, Fraud Section Tony Maida, Partner, McDermott Will & Emery Jillian Sparks, Senior Counsel, Industry Guidance Branch, U.S. Department of Health and Human Services, Office of Counsel to the Inspector General View Description

<

ul>